The medicine is intended to treat a lung disease called idiopathic pulmonary fibrosis (IPF) in adults. • The medicine is intended to treat adults with chronic (long lasting) fibrosing interstitial lung disease (ILD) with a progressive phenotype.•The medicine is intended to slow the rate of decline in pulmonary function in patients with systemic sclerosis associated with interstitial lung disease.
Reviews
There are no reviews yet.